The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
A total of 2% of children around the world are diagnosed with an autism spectrum disorder. Most struggle with clear communication and verbalization, making it difficult for the child to communicate their needs to others. An AI-powered app created by SocialMind Autism, led in part by Technion alumna and company CTO Dana Porrat, may hold the solution to this problem. The app gives parents and caregivers practical guidance on moments of attempted verbalization they may have otherwise overlooked, mainly targeting children under five as those years are the most critical in building language skills. SocialMind Autism gives personalized feedback within…
Pictured Above / L-R: Amir Livne, Dr. Gil Shamai and Prof. Ron Kimmel One in nine women globally will be diagnosed with breast cancer during their lifetime, and the numbers are only increasing as a result of factors, including increased lifespan and modern lifestyles. Personalized immunotherapy treatment is a necessity now more than ever, but the number of doctors and pathologists who specialize in examining tissue for specific diagnoses needed for personalized medicine is declining. To help combat this problem, Technion researchers have developed an artificial intelligence (AI) neural network that simplifies and improves the diagnostic process. Even better, the…
A third of all food crops are destroyed by diseases annually, which worsens existing global food insecurity. The standard treatment with synthetic fungicides for such diseases is highly toxic, with devastating impacts on soil, crops, wildlife, and consumers. The crops become immune to the fungicides over time, ultimately leaving the plants defenseless. In hopes of solving this pressing issue, researchers at the Technion have developed an environmentally friendly, natural protective spray. Inspired by the natural properties found in the wax crystals that present on lotus and broccoli, the SafeWax anti-adhesive spray is a biodegradable formulation made of non-toxic renewable material….
Drowning is the leading cause of accidental deaths for children under five – and most of these tragedies happen despite close adult supervision in private swimming pools. Children under the age of five generally do not struggle, shout, or splash before they drown but instead slowly sink to the bottom of the pool without alerting an adult that they need help. To combat these heartbreaking tragedies, Israel-based startup Coral Smart Pool has created an AI-powered lifeguard that scans the pool constantly for potential drowning risks. The virtual lifeguard, Mylo, uses cameras both above and below the water to track movement…
Transformational Gift Funds New Center to Accelerate a Sustainable Future The Technion-Israel Institute of Technology announced today that American philanthropists Lynda and Stewart Resnick, co-owners of California-based The Wonderful Company, have pledged, through their foundation, a $50 million gift to transform the university’s research and development of sustainability and catalysis. The $50 million gift will establish the Stewart and Lynda Resnick Sustainability Center for Catalysis, designed to empower faculty and students to uncover new ways to maintain global growth while protecting the planet for future generations. The pledge is the latest in a series of gifts by the Resnicks’ foundation…
Imagine restaurant menus with selected dishes for men and others exclusively for women, or supermarket products categorized by gender. Looking even further into the future, what about designer 3D cultivated steaks that are male- or female-specific? Using simulated digestive systems, Technion scientists have identified differences in the way men and women digest food that could help tailor healthier food solutions by gender. The study, published recently in Food Hydrocolloids, was prompted by research recognizing that some medications are more effective in treating a specific gender, and that the same drug can have different side effects in men versus women. “We…
Valvular heart disease is the term used to describe when any valve in the heart is damaged or diseased. According to the U.S. Centers for Disease Control and Prevention, about 2.5% of the U.S. population has valvular heart disease – but it is more common in older adults. When any of the heart’s valves are diseased, they are unable to fully open or close to allow proper blood flow from one area of the heart to the next or in the correct direction it needs to move. In more severe cases, treatment can require open heart surgery. A new alternative…
Startup H2Pro, founded by Technion scientists, has signed an agreement with Morocco’s Gaia Energy to co-develop a gigawatt-scale “green” hydrogen energy project — a potential boon for promoting economic ties between the two countries and combatting climate change. “Climate change is the greatest challenge facing our generation, and it can only be solved by reaching across borders with seamless coordination between the private and public sector,” said Talmon Marco, CEO of H2Pro. The technology at the core of H2Pro was developed by Professors Avner Rothschild and Gideon Grader and Drs. Hen Dotan and Avigail Landman in the Nancy and Stephen…
Pictured Above / (left to right) Prof. Inbal Talgam-Cohen, Prof. Ofra Amir, Prof. Noga Ron-Harel, and Prof. Naama Geva Zatorksy Four Technion scientists – all of whom are women – have been awarded early career Starting Grants by the European Research Council (ERC). The prestigious grants are used to further the research of those who demonstrate great potential in their fields of study. The quartet of awardees, who all come from different Technion faculties, are Assistant Professor Ofra Amir, Assistant Professor Naama Geva-Zatorsky, Assistant Professor Noga Ron-Harel, and Assistant Professor Inbal Talgam-Cohen. Prof. Ofra Amir’s research centers around the intersection…
Recently, a team of 12 Technion undergraduates competed in the prestigious iGEM competition in Paris, France. Led by Maia Lehrman, they presented their research for developing a way to reduce hair loss in chemotherapy patients by using a bacteria called decursin. Decursin is derived from a plant, Angelica gigas – grown exclusively in China and Korea – that has the ability to prevent apoptosis, or programmed cell death, including in hair cells. The project focused on engineering bacteria enzymes to create more decursin bacteria, since the plant is very rare and only contains a small amount of decursin. Their ultimate…
When other little girls were playing with dolls, Debra Javit was walking with her Dad through the shopping malls he developed in suburban Connecticut. “I always wanted to be like him and to be with him,” Debra said. So it came as no surprise that Debra built a career in commercial real estate, and when the opportunity presented itself, she became a philanthropist like her parents Max and Rachel Javit, and a second-generation Technion supporter. The family story started in Brooklyn for Max and Israel for Rachel. “They came from nothing,” Debra said. Her Dad wanted to be a farmer….
Periodontitis, or gum disease, affects 40% of adults worldwide. It is also a common ailment in pets, frequently found in dogs. But help with Fido’s oral health has arrived, thanks to BioChange, a startup led by Technion alumnus Founder and CEO Ishay Attar. The company has developed a new technology that has proven to be effective in healing periodontitis in dogs and may work well on humans in the future. Called ReGum, it regenerates the tissue to reduce receding gum lines and heal infection. ReGum is a novel scaffold implant made of natural biomaterials that causes the patient’s own cells…